CANNABIS EUROPA LONDON 2019: STANDING ROOM ONLY

CANNABIS EUROPA LONDON 2019: STANDING ROOM ONLY

In the heart of London, on the south bank of the River Thames, over 1200 delegates gathered in the auditoriums of the Queen Elizabeth Hall to hear from cannabis industry experts from the worlds of politics, finance, healthcare and science. Cannabis Europa London, Europe’s premier medical cannabis conference, brought together key stakeholders to tackle the toughest questions facing the European cannabis industry. In his opening address George McBride, co-founder of Cannabis Europa, told the packed-out audience, “Around the world countries are changing their laws at an ever-increasing pace to allow access to medicines derived from this fantastic plant. I want...

ANNOUNCING HALO AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING HALO AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Halo as a Bronze Partner for our London conference this June at the Southbank Centre. Halo is a cannabis extraction company that develops and manufactures quality cannabis oils and concentrates, which are the fastest growing segments in the cannabis industry.  Halo is a global leader in cannabis oil and concentrates and has expertise across as major cannabis manufacturing processes, leveraging proprietary processes and products, and has produced over 4.0M grams of oils and concentrates since inception.  The forward-thinking company is led by a strong management team with deep industry knowledge and blue-chip experience.  The...

ANNOUNCING MILE HIGH LABS AS THE POST-CONFERENCE DRINKS PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING MILE HIGH LABS AS THE POST-CONFERENCE DRINKS PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Mile High Labs as the Post-Conference Drinks Partner for our London conference this June at the Southbank Centre. Mile High Labs is a large-scale CBD ingredient and product manufacturer offering reliable delivery of bulk CBD and private label services to the world’s leading consumer brands. With a GMP-certified facility and extensive network of contracted cultivators, Mile High Labs supplies high-quality, high-volume CBD orders year-round. Mile High Labs extracts exclusively from industrial hemp material. More at www.milehighlabs.com. “Cannabis Europa is a fantastic event that attracts a great representation of key EU industry players, from fellow...

ANNOUNCING CANACCORD GENUITY AS THE WELCOME DRINKS PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING CANACCORD GENUITY AS THE WELCOME DRINKS PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Canaccord Genuity as the Welcome Drinks Partner for our London conference this June at the Southbank Centre. Canaccord Genuity is the global capital markets division of Canaccord Genuity Group Inc., offering institutional and corporate clients idea-driven investment banking, merger and acquisition, research, sales and trading services from offices in North America, UK & Europe, Asia, Australia and the Middle East. Our diverse team of capital markets and advisory professionals has deep industry and transactional expertise in key growth sectors of the global economy. We are committed to providing valued services to our clients throughout...

ANNOUNCING NEXT GREEN WAVE AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING NEXT GREEN WAVE AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Next Green Wave as a Silver Partner for our London conference this June at the Southbank Centre. Next Green Wave is a premium California cannabis consumer goods company, focused on unlocking the full potential of the cannabis plant through research, innovation and its high-quality products. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe, dedicated to creating a platform for European leadership in the global cannabis industry. Leaders gather for thought-provoking panel discussions that aim to solve uniquely European issues facing this nascent industry, welcoming...

POLITICAL: EUROPE’S ROLE IN THE INTERNATIONAL CANNABIS MARKET

POLITICAL: EUROPE’S ROLE IN THE INTERNATIONAL CANNABIS MARKET

Europe’s role in the international cannabis market has so far been relatively minor compared to booming industries in the US and Canada. Whilst the continent has been historically strong in the pharmaceutical sector, it has been comparatively slow to develop domestic medical cannabis markets. Having said this, there is enormous market potential in Europe, which has a population of over 700 million people and a GDP worth €2.3 trillion. In addition, there has been a gradual movement in recent years towards legalising medical cannabis, increasing access for patients. With this, a plurality of models has emerged across the continent. Some,...

ANNOUNCING BRAINS AS A POST-CONFERENCE DRINKS PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING BRAINS AS A POST-CONFERENCE DRINKS PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Brains Bioceutical Corp as a Drinks Partner for day two for our London conference this June at the Southbank Centre. Brains Bioceutical Corp (“Brains”) is a globally recognized leader in GMP-certified production of naturally-sourced Active Pharmaceutical Ingredients (API) for the pharmaceutical and nutraceutical industries. Brains offers bulk CBD API currently through its Laboratory Production division and Brains is sourcing raw materials from its global Extraction Partnerships division. In the future, Brains plans to develop new APIs for commercial use and will create three new divisions to continue its expansion, R&D & Innovation, Manufacturing, and...

ANNOUNCING MEDCANN PHARMA AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING MEDCANN PHARMA AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce medcann pharma as a Bronze Partner for our London conference this June at the Southbank Centre. medcann is a Canadian registered company with its roots firmly in Colombia, dedicated to a long-term strategy to be a fully integrated medicinal cannabis company. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe, dedicated to creating a platform for European leadership in the global cannabis industry. Leaders gather for thought-provoking panel discussions that aim to solve uniquely European issues facing this nascent industry, welcoming medcann as a leader...

ANNOUNCING VALENS AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING VALENS AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Valens as a Silver Partner for our London conference this June at the Southbank Centre. Valens is a British-Columbia based company specialising in extraction, testing, formulation and product developmentof medical cannabis. With partnerships across the world and plans to process in Europe under EU GMP certification, achieving the highest quality is personal, and what makes Valens the “best in class”. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe, dedicated to creating a platform for European leadership in the global cannabis industry. Leaders gather for...

EUROPEAN CANNABIS PATIENT EXPERIENCES

EUROPEAN CANNABIS PATIENT EXPERIENCES

By Bill Griffin Patients will benefit from cannabis at a consistent rate across Europe. Sadly, medical cannabis is far from harmonised at an EU level, resulting in very different patient experiences depending on which country you live in. As Cannabis Europa approaches, our correspondent, Bill Griffin, details five patient stories from across the continent, showing the lack of consistency in both prescriptions and product. GERMANY: RICHARD Richard is an expat living in Germany. He was seeking medical cannabis to ease the discomfort he suffered after a bout of Lyme disease and an operation to remove 25cm of his colon. He...

ANNOUNCING PRØHBTD AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING PRØHBTD AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce PRØHBTD as a Bronze Partner for our London conference this June at the Southbank Centre. PRØHBTD is a hybrid consumer goods and content company recognised as the exclusive global cannabis partner of Licensing Expo, Advertising Week, All Def Media, Postmedia, and Entrepreneur Magazine. The company is venture-backed with over USD $20 Million in funding and has offices in Los Angeles, Toronto, New York and Vancouver. Cannabis Europa is the foremost arena to share knowledge and shape the future of cannabis policy in Europe, dedicated to creating a platform for European leadership and paving the...

ANNOUNCING CANNAMEDICAL® PHARMA AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING CANNAMEDICAL® PHARMA AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Cannamedical® Pharma as a Bronze Partner for our London conference this June at the Southbank Centre. Cannamedical® Pharma is a GDP-certified and fully licensed pharmaceutical wholesaler in accordance with the German Medicines Act (AMG) and licensed narcotics dealer in accordance with the German Narcotics Legislation. In addition, the company is permitted to import narcotic medicines into Germany and export to member states of the European Union (EU) and beyond. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe, dedicated to creating a platform for European...

ANNOUNCING CLEVER LEAVES AS A POST-CONFERENCE DRINKS PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING CLEVER LEAVES AS A POST-CONFERENCE DRINKS PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Clever Leaves and its brand Esenia as a Post-Conference Drinks Partner for day one of our London conference this June at the Southbank Centre. Clever Leaves is a vertically-integrated licensed producer of medical cannabis in Colombia. Clever Leaves objective is to become the biggest medical cannabis company in the world, with more than 100 hectares of cultivated land, state of the art laboratory, GACP and GMP certified, assuring the highest quality standards in the field. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe, dedicated...

ANNOUNCING THE SUPREME CANNABIS COMPANY INC. AS THE GOLD PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING THE SUPREME CANNABIS COMPANY INC. AS THE GOLD PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce The Supreme Cannabis Company, Inc. as the Gold Partner for our London conference this June at the Southbank Centre. The Supreme Cannabis Company, Inc. (TSX: FIRE), is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, Supreme has emerged as one of the world’s fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products. “We live in such an exciting time; we are part of an industry that is growing at unprecedented rates and has the opportunity to deliver many positive benefits...

ANNOUNCING DRAGONFLY AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING DRAGONFLY AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Dragonfly Biosciences as a Bronze Partner for our London conference this June at the Southbank Centre. Dragonfly Biosciences is Europe’s largest and leading producer of cannabidiol (CBD) and cannabis-derived extracts. After rapid growth in the past two years, it now boasts a head office in London, farms and formulation facilities in Bulgaria, and partner companies in Poland, Canada and Malta. A seed-to-sale producer, Dragonfly’s reach is bolstered by 650 hectares of organically certified, fully irrigated farmland – a capacity soon to rise. Cannabis Europa is the foremost arena to share knowledge and shape the...

ANNOUNCING TORONTO STOCK EXCHANGE AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING TORONTO STOCK EXCHANGE AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Toronto Stock Exchange as a Bronze Partner for our London conference this June at the Southbank Centre. Canada’s premier equities exchanges, Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) are home to over 3,000 listed companies with a total market capitalisation of almost $3 trillion (CAD). Together, TSX and TSXV represent the world’s most successful two-tiered ecosystem for supporting the long-term success of issuers across a wide range of sectors, with over 650 companies graduating from the junior to the senior market since 2001. Cannabis Europa is the foremost arena to share knowledge...

ANNOUNCING CANNEX CAPITAL/4FRONT VENTURES AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING CANNEX CAPITAL/4FRONT VENTURES AS A BRONZE PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce Cannex Capital / 4Front as a Bronze Partner for our London conference this June at the Southbank Centre. The British Colombia-based Cannex Capital and US-based 4Front pending partnership encompasses proven management and operational skills in large-scale indoor cultivation facilities that boast industry-leading yields, the manufacturing and branding of infused products, edibles and other derivative products, and proven experience managing curated customer-centric retail operations. Cannex Capital / 4Front will create a multi-state vertically integrated powerhouse, serving as an example of how to achieve excellence through partnership. “We look forward to bringing our experience in the...

ANNOUNCING MGC PHARMACEUTICALS AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

ANNOUNCING MGC PHARMACEUTICALS AS A SILVER PARTNER FOR CANNABIS EUROPA LONDON

Cannabis Europa is excited to announce MGC Pharmaceuticals as a Silver Partner for our London conference this June at the Southbank Centre. MGC Pharmaceuticals (ASX:MXC, OTC US: MGCLF) is an EU based bio-pharma company, creating a seamless pipeline of high quality, pharmaceutical grade products, taking advantage of the medical value of phytocannabinoids. MGC Pharma’s goal is to facilitate the transformation of phytocannabinoids into true medicinal product pipelines, and to provide breakthrough solutions for prevalent global health issues to improve the quality of patients’ lives. Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis...

HEALTH-TECH AND BIG DATA: SHAPING THE MODERN CANNABIS INDUSTRY

HEALTH-TECH AND BIG DATA: SHAPING THE MODERN CANNABIS INDUSTRY

Medical cannabis has the opportunity to be the first modern medical industry that is built with a digital-first approach. Technology is already providing ways to educate people, empower patients, fuel innovation and feedback into the product development cycle. For example, while governments struggle to develop the infrastructure for a medical cannabis industry – or indeed even drag their feet in terms of acknowledging the medical benefits of cannabis-based products – the Internet can provide information and education. In the UK, patients are struggling to access medical cannabis partly due to a lack of training and knowledge in the medical community...

CBD AND SPORT: PERMEATING THE MAINSTREAM

CBD AND SPORT: PERMEATING THE MAINSTREAM

As CBD has permeated popular consciousness, athletes across the world have shared stories about how they use CBD and cannabis products as part of their training and recovery. As sales and popularity soar, consumers and brands are pushing regulators to keep up with the industry. In January 2018, cannabidiol (commonly known as CBD) was removed from the World Anti-Doping Agency’s (WADA) list of banned substances. WADA, led by the International Olympic Committee (IOC), is responsible for the World Anti-Doping Code which aims to harmonise anti-doping regulations in all sports and countries. It has been adopted by more than 600 sports...